About the Psychedelic Society of India

​MISSION AND HISTORY

The Psychedelic Society, along with other organisations and individuals listed below, are calling on the Indian government to reschedule Entheogens, a natural occuring compounds found in hundreds Plants, that has been called a ‘breakthrough’ treatment for mental health & Spiritual Growth.

Recent trials using psilocybin to treat depression and anxiety have returned staggering results, with 80% of patients reporting significantly improved wellbeing or life satisfaction for up to six months from just a single dose.

Psilocybin is currently a Schedule 1 substance. Schedule 1 substances are not authorised for medical use and can only be supplied, possessed or administered in exceptional circumstances under a special Home Office licence. This means psilocybin cannot be prescribed by doctors, and that conducting research with it is extremely time-consuming and expensive.

By rescheduling psilocybin from Schedule 1 to Schedule 2 or below, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.

STAFF

ADMINISTRATION

SUPPORT STAFF

CENTER

PROGRAMMING

CLINICAL

DEPARTMENT

​PAUL MATTHEWS

AARON SWARTZ

OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG

AARON SWARTZ
OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG
PAUL MATTHEWS

KATE STONE
STELLA RICCI

LYDIA DOYLE
OLIVER PARKER
OWEN WRIGHT
PARKER LUDWIG

PARKER LUDWIG

KATE STONE
AARON SWARTZ
OLIVER PARKER
OWEN WRIGHT

BOARD

JANE DOE

PRESIDENT

JOHN DOE

VICE PRESIDENT

JOHN DOE

TREASURER

JANE DOE

CO-SECRETARY

Psychedelic Society

of India

SUBSCRIBE:​​

Subscribe for Updates

CONNECT​ WITH US:​​

  • w-facebook
  • Twitter Clean
  • w-tumblr
  • Facebook
  • Facebook

© 2020 by

Psychedelic Society of India